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ABSTRACT 
Chrysanthemum cinerariifolium (C. cinerariifolium) is an empirically proven 
medicinal plant that has anticancer activities. This study aimed to profile metabolites, and 
cytotoxic activity of root, leaf, stem, and root extracts C. cinerariifolium on T47D cells and to 
determine the correlation of metabolite content with cytotoxic activity. The metabolite profile 
was carried out using UPLC-QToF-MS / MS, and cytotoxic activity was carried out using the 
MTT method. The results obtained in the form of a chromatogram were processed with the 
application Masslynk so that a metabolite profile data obtained. The data is then analyzed 
statistically using Principal Component Analysis (PCA). The results obtained on metabolite 
profiling showed that there were differences in metabolite profiles in the roots, stems, leaves, 
and chrysanthemums. The characteristic compounds in the flower section are D - (-) - 
Morphine and in the leaf part of genistein  and N - [(5-Chloro-1,2,3-thiadiazol-4-yl) methyl] -
1- (2-isopropyl-4 -methyl-1,3-thiazol-5-yl) -N-methyl ethanolamine. The major compounds in 
the roots, stems, and leaves are Orphenadrine with successive percentages of 9.11%, 10.16%, 
and 3.24%, and the major compounds in the flower section are D - (-) - Morphine with a 
percentage of 10, 86%. Furthermore, the results of the cytotoxic activity test showed 
differences in anticancer cytotoxic activity in the parts of the flower, leaf, stem, and root of C. 
cinerariifolium. Besides, there is a relationship between the metabolite content and anticancer 
cytotoxic activity of each part of C. cinerariifolium. The higher the level of orphenadrine 
compounds in the plant, the higher the potential for anticancer.  
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INTRODUCTION 
 
Chemoprevention is the use of natural materials to prevent (stop the activation of 
carcinogens, blocking) at the stage of initiation of carcinogenesis pressing (suppressing) 
cancer growth and restoring (reversing) the normal function of cellular regulation so as to 
reduce the development of cancer or reduce the possibility of progressive to invasive cancer 
[1][2]. Some chemoprevention agents from natural materials show high potential to be 
developed when clinically tested so that it becomes a priority for further research, including 
flavonoid and polyphenol compounds such as quercetin, luteolin, biochanin A, genistein [3]. 
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One of the traditional medicinal plants which are rich in the content of quercetin flavonoids 
is chrysanthemum (Chrysanthemum cinerariifolium). 
Chrysanthemum flower (Chrysanthemum cinerariifolium) is a plant of the family 
Asteraceae which has been used by the community as an ornamental plant because of its 
beautiful flowers. Empirical evidence (traditional use) shows that chrysanthemum plants have 
widely used as antibacterial, anti-inflammatory, hypo-allergenic, and anticancer drugs [4][3]. 
Previous studies reported that chrysanthemums have potent anticancer activity [5]. It is also 
said that the most dominant compounds in chrysanthemum plants are terpenoid compounds 
and flavonoid compounds [6]. These compounds can act as anticancer. In breast cancer, 
flavonoid compounds and terpenoid groups play a role in inhibiting the mutation of the p53 
gene so that it prevents excessive cell proliferation and can increase cell apoptosis [7][8]. The 
results of the antitumor activity test extracts of red chrysanthemums (Chrysanthemumkunlun) 
in vitro stated that flower extract C. kunlun could inhibit cell growth of Eca-109, H22 cells 
and HeLa cells [9].  
Ophthalmology of secondary metabolites in a plant or natural product is a method that 
has widely developed today. One of the advantages of this method is that the stages of 
finding active compounds are shorter and require fewer samples than the method Bioassay-
Guided Isolation.  Also, metabolite profiling can be done to maintain the quality and 
consistency of the raw materials of herbal products used as traditional standardized 
medicines. Secondary metabolites are used not only from one organ part of the plant such as 
leaves, but rarely used parts do not rule out the possibility of containing secondary 
metabolites that have the potential to be developed, such as roots, stems, and flowers. It can 
be quickly done using an UPLC-QToF-MS/MS instrument. Based on this description, in this 
study profiling of metabolites and their correlation with the cytotoxic activity of extracts of 
flowers, leaves, stems, and roots of Chrysanthemum cinerariifolium (Trev.) On T47D breast 
cancer cells. 
 
MATERIALS AND METHODS 
Cell line and Reagents 
The cell line used was T47D cells obtained from the Parasitology Laboratory of the Faculty 
of Medicine, Gadjah Mada University, Yogyakarta. The materials used for the test are the 
radix, caulis, folium, and flos C. cinerariifolium, technical ethanol 96%, and distilled water, 
n-hexane, ethyl acetate, H2SO4 10%, Complete RPMI 1640 medium (Gibco , USA), MK 
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MI99 (Gibco, USA), PBS, Trypsin-EDTA, DMSO (EMSURE ACS, Japan), SDS (Merck, 
Germany), ethanol extract 96% flower, ethanol extract 96% leaf, ethanol extract 96% stem , 
ethanol extract 96% of plant roots C. cinerariifolium, doxorubicin HCL 50 mg, and MTT 
solution (Bio Basic Canada Inc, Canada). 
Plant Determination  
Determination of  Plants was C. cinerariifolium (Trev) carried out at UPT Materia Medika 
Batu, East Java, Indonesia by number: 074/374/10272017 Plant specimens stored in the 
Pharmacognosy Laboratory of the Pharmacy Department of the Medical Faculty of Maulana 
Malik Ibrahim Malang. 
Ethical Clearance 
This research has received ethical approval from the Health Research Ethics Commission 
(KEPK) of the Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim the Islamic 
State University of Malang on April 23, 2018, with numbers 004 / EC / KEPK-FKIK / 2018. 
Sample Preparation 
Sample C.cinerariifolium harvested by cut each piece of flowers, leaves, stems, and roots. 
Then each part is sorted early, washed, dried under the sun, and finally sorted. The dry 
sample is fertilized with a grinding machine and then weighed the powder. 
Extraction of C. cinerariifolium The 
Powder of flowers, leaves, stems, and roots of C. cinerariifolium put into Erlenmeyer and 
ethanol 96% added with a ratio of 1:20. Mixture extracted using UAE (Ultrasonication 
Assisted Extraction) for 2 minutes with three replications. The filtrate for each part of C. 
cinerariifolium from UAE was evaporated using a rotary evaporator at a temperature of 50oC 
to produce the crude extract. A crude extract of flowers, leaves, stems, and roots concentrated 
using an oven at a temperature of 40oC until the texture of the extract becomes concentrated. 
Percentage of rendement calculated by the formula: 
% rendement=
𝐸𝑥𝑡𝑟𝑎𝑐𝑡𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑒𝑥𝑡𝑟𝑎𝑐𝑡
𝑆𝑖𝑚𝑝𝑙𝑖𝑐𝑖𝑎 𝑤𝑒𝑖𝑔ℎ𝑡
× 100% 
Thin Layer Chromatography (TLC) 
In the identification of compounds with TLC silica gel plate, 60 F254 used as a stationary 
phase by optimizing mobile phase n-Hexane and ethyl acetate (5: 5); (7: 3); and (8: 2). While 
the appearance of the stain used is H2SO4 10%. Identify compound stains using the Thin 
Layer Chromatography (TLC) Visualizer. 
Sample preparation for Analysis of Metabolite Profiling 
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Determination of the metabolite types of ethanol extract of roots, stems, leaves, and 
chrysanthemums using the UPLC-QToF-MS/MS instrument with three replications. 
Carefully weighed 10.00 mg of ethanol extract of roots, stems, leaves, and chrysanthemum 
flowers, then dissolved in methanol into a 10 ml volumetric flask and added microsyringe 
was 5 µl. The applied liquid was a mixture of (A) Water (HPLC grade) / formic acid (Merck, 
Darmstadt, Germany) 99.9 / 0.1 [v / v]; (B) Acetonitrile (Merck, Darmstadt, Germany) / 
formic acid 99.9 / 0.1 [v / v] and the system of gradient elution. The comparison presented in 
Table 1. Data obtained in the form of a chromatogram processed using software Masslynk 
version 4.1, so the data is in the way of peak area and m / z spectra of each detected peak and 
database www.chemspider.com. The data profile is then analyzed statistically by Principal 
Component Analysis (PCA) using software Minitab version 17.0. 
Statistical Analysis  
The identification data from the extract component was classified based on the sample origin, 
and the percentages of the area were analyzed using the Principal Component Analysis 
(PCA) to get the loading plot and score plot. PCA was performed using Minitab 17 (Minitab 
Inc, Pennsylvania, USA) 
Preparation of Samples for Cytotoxic Activity Test 
Flower, leaf, stem, and root extracts weighed as much as 10 mg, dissolved with 
DMSO and made seven kinds of concentration series namely 1000; 800; 600; 400; 200; 100; 
50 µg / mL. The positive control of doxorubicin is made with 7 types of concentration, 
namely 2000; 1000; 500; 250; 125; 62.5; 31.25 nM  
Cytotoxicity Test  
Cytotoxicity tests were carried out on T47D cell cultures with RPMI medium. T47D cell 
culture was grown on 96 well plates and then incubated for 24 hours. After 24 hours the 
media was removed and washed with PBS, then each series of extract concentrations was 
inserted into each well with three replications and incubated for 24 hours. After 24 hours the 
media was removed and washed with PBS, then added MTT reagent 100 µL to each well, 
including media control (without cells), then incubated again for 4 hours in a CO2 incubator. 
After 4 hours the cell conditions under the inverted microscope were observed. Then a 
stopper of 100 µL SDS 10% was added and incubated at room temperature for one night. 
Then read the absorbance value using ELISA reader and calculated cell viability using the 
following formula: 
23 
J. Islamic Pharm. 2019. 4(1): 19-39 
 
J. Islamic Pharm., an open access journal 
ISSN: 2527-6123 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
(𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑎𝑏𝑠 −  𝑚𝑒𝑑𝑖𝑎 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
𝑎𝑏𝑠(𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑎𝑏𝑠 −  𝑚𝑒𝑑𝑖𝑎 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑎𝑏𝑠) 
×  100% 
Results of cell viability obtained are carried out IC50 analysis using Microsoft Excel. 
Then the data were analyzed by one way ANOVA to determine the cytotoxicity differences 
of each sample. 
Correlation Analysis of Metabolic Content and Cytotoxic Activity  
Analysis of the correlation of metabolite content and cytotoxic activity was carried 
out using the Pearson correlation test. Pearson correlation test was used to test two variables, 
namely the percentage levels of orphenadrine compounds from parts of flowers, leaves, 
stems, roots with cytotoxicity activity in T47D cells. Correlation test results indicate whether 
there is a correlation between metabolite content and cytotoxic activity in that part. 
RESULTS 
Thin Layer Chromatography (TLC) 
Thin Layer Chromatography (TLC) is a physicochemical separation method based on 
two phases, namely the mobile phase in the form of liquid and the stationary phase in the way 
of solids [10]. 
The optimization results obtained showed the best mobile phase in n-hexane and ethyl 
acetate (8: 2) by comparing before and after derivatization with H2SO4 10%. The results of 
the identification of TLC visualizers with UV 366 light showed differences in the separation 
of compounds between before and after spraying. The TLC plate after spraying shows many 
stains with several colors. It can be seen in the results of the Rf obtained, the compound Rf on 
the TLC plate after spraying was more than the value of Rf on the TLC plate before spraying. 
The amount of TLC Rf plate after spraying on flower, leaf, stem, and successive extracts is 9; 
8; 10; and 11. According to Harborne [11], the yellow color with wavelengths 341-389 after 
being sprayed showed flavonol compounds and red-purple indicating terpenoid compounds. 
Whereas according to Muti'ah et al., [10] purple stains are suspected as sesquiterpenes. 
Flavonoid compounds and terpenoid groups play a role in health, one of which is to have 
anticancer activities [7][12]. 
Based on Figure 1 shows that there are differences in the chromatogram profile on the 
flowers, leaves, stems, and roots of C. cinerariifolium. The difference in the chromatogram 
indicates that there are differences in the metabolite content in each part of the organ C. 
cinerariifolium . 
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Analysis of Metabolite Profiling with UPLC-QToF-MS/MS 
The results obtained from the UPLC-QToF-MS/MS instrument were in the form of a 
chromatogram. The compounds that appear early on the peak chromatogram are polar 
compounds, and their polarity decreases at the peak next. At this stage, repetition carried out 
until a constant peak chromatogram obtained. The chromatogram obtained was processed 
using the application Masslynx version 4.1, so that the m/z spectra of each can be displayed 
peak on the chromatogram. Each peak of the chromatogram indicates the presence of one 
compound. Figure 2 is the result of a chromatogram of plant extract C. cinerariifolium. Based 
on the results of the chromatogram interpretation obtained from each peak, the prediction 
data found on chrysanthemum plants presented in table 2. It shows that there are differences 
in the compound content of the roots, stems, leaves, and flowers of C. cinerariifolium. Of the 
four parts of the organ, there is one dominant compound where the percentage greater than 
the other compounds, the compound is Orphenadrine (Figure 3). Orphenadrine is a flavonoid 
group compound that has activity tumor-preventing liver [13]. Figure 4, 5 and 6 are spectra of 
m/z compounds and the structure of the characteristic compounds found in parts of the 
chrysanthemum plant.  
Statistical Analysis Principal Component Analysis 
Principal Component Analysis (PCA) is a mathematical method for reducing data, to 
reduce the dimensionality of a series of data and reveal a cluster [14]. The data used in the 
PCA analysis are data on the name of the compound found and the percentage of the area of 
the chrysanthemum plant (roots, stems, leaves, flowers). The results of the PCA analysis 
obtained are loading plots and plot scores (Figure 7). Loading plots show compounds that are 
thought to be characteristic compounds in parts of chrysanthemum plants. In this study 
marker compounds were specific compounds not found in other parts of the plant. The 
compound is D - (-) - Morphine (Figure 4) found in the flower section and in the leaf part N - 
[(5-Chloro-1,2,3-thiadiazol-4-yl) methyl] -1- (2-isopropyl-4-methyl-1,3 -thiazol-5-yl) -N-
methylethanamine and genistein (Figures 5 & 6). 
Based on Figure 5 shows that Loading plots can interpret the characteristic 
compounds in the flower section are D - (-) - Morphine and in the leaf part is N - [(5-Chloro-
1,2,3-thiadiazol-4-yl) methyl] -1- (2-isopropyl-4- methyl-1,3-thiazol-5-yl) -N-
methylhexanamine and genistein, whereas in the roots and stems there are no organ 
compounds found. The plot score shows that the contents of the root and stem compounds of 
C. Cinerariifolium have close physical and chemical properties. 
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Cytotoxic test for t47D cells Cytotoxicity 
The analysis aims to determine the anticancer cytotoxic differences of the parts of the 
flowers, leaves, stems, and roots of C. cinerariifolium by decreasing the percentage of living 
cells based on 50% Concentration (IC50) [15]. Cytotoxicity tests were carried out on T47D 
cells. The results of the cytotoxicity test presented in Figure 8 and Table 4.  
Based on the results of IC50 values in Table 3, extracts that have cytotoxic activity 
against T47D cells are extracts of leaves, stems, and roots. An extract otherwise has a high 
cytotoxic activity when the value of IC50 <500 mg / mL and is said to have a weak activity 
where the IC50 values>500 pg / mL [16]. The IC50 amount of positive control is 208.82 nM. 
The results obtained were close to the value of IC50 researcher which stated that the IC value 
of50 doxorubicin for T47D cells was 250 nM. Doxorubicin hasIC50 a low value because it has 
high activity against breast cancer cells [17]18]. 
Correlation Analysis of Metabolite Content with Cytotoxic Activity 
The results of the correlation analysis between metabolite profiles and cytotoxic 
activity shown in Table 4. Based on Table 4, the results obtained indicate that there is a 
significant correlation between orphenadrine levels and anticancer activity in the flower 
section, stem, and roots. Relationship of orphenadrine compounds with cytotoxic activity is a 
negative correlation. It shows a correlation in the opposite direction, where the higher the 
level of orphenadrine compounds, the smaller the IC50 value. Based on the results of these 
correlations, the higher the content of the compounds in the plant C. cinerariifolium, the 
higher the anticancer potential.  
 
DISCUSSION 
Metabolite profiling aims to determine differences in the content of compounds in the 
roots, stems, leaves, and flowers of C. cinerariifolium and determine the characteristic 
compounds and major compounds with statistical analysis Principal Component Analysis 
(PCA). Metabolite profiling is carried out using the UPLC-QTof-MS / MS instrument that 
offers high resolution, speed, and sensitivity, and is effective for identifying the structure of 
components of natural and mixed organic compounds [19]. The findings of the compounds in 
the roots, stems, leaves, and flowers of C. cinerariifolium predicted by UPLC-QTof-MS / MS 
showed differences in compound content. The difference in the compound content of a part 
of a plant can be influenced by differences in the process of synthesizing compounds at 
certain stages so that a complex production of compounds occurs. The results of the profile of 
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the binding compounds in section C. cinerariifolium were then analyzed by Principal 
Component Analysis (PCA) to determine the characteristic compounds and major 
compounds. Identifying compounds are specific compounds that only found in parts of the 
organ of C. cinerariifolium. The compound is D - (-) - Morphine found in the flower section 
and N - [(5-Chloro-1,2,3-thiadiazol-4-yl) methyl] -1- (2-isopropyl-4-methyl- 1,3-thiazol-5-yl) 
-N-methylhexanamine and genistein in the leaf part. Further identification is a major 
compound which is the dominant compound with the largest percentage of area in each part. 
The major compounds in the flower section are D - (-) - Morphine at 10.86%, and in the 
roots, stems, leaves are Orphenadrine in the amount of 9.11%, 10.16%, and 3.24% 
respectively. 
As a result of the metabolite profiling with UPLC-QToF-MS / MS, it is shown that in 
each part C. cinerariifolium contained a major compound, the compound Orphenadrine. 
Compound Orphenadrine is a flavonoid compound [13]. Flavonoid compounds have been 
reported to have antiproliferative effects on breast cancer cells and can induce cell apoptosis 
[17][12][19][20]. Each part of C. cinerariifolium is known to have different levels of 
compounds orphenadrine, while the compounds highest Orphenadrine found in stem part 
extracts of 10.16%. 
The cytotoxic activity test aims to determine the differences in the anticancer 
cytotoxic activity of the flowers, leaves, stems, and roots of C. cinerariifolium. The value of 
anticancer cytotoxicity in each part shows different data. It is because the content of 
orphenadrine compounds in each section also shows different levels. In the flower section, 
there are 8% orphenadrine compounds, with IC50 T47D cells of 782.33 µg / mL. In the leaf 
contains orphenadrine compounds of 2%, with IC50 values of 362.58 µg / mL. In the stem 
contains 10.16% orphenadrine compounds with IC50 values of 168.46 µg / mL. Whereas at 
the root part contains orphenadrine compounds of 9.11% with IC50 values of 293.81 µg / mL. 
Analysis of the relationship of orphenadrine compounds with anticancer cytotoxicity 
was carried out using Pearson correlation analysis. The results obtained showed that there 
was a significant correlation between the levels of orphenadrine compounds and anticancer 
activity in the flower, stem, and root parts, with P <0.05. The higher the level of orphenadrine 
compounds, the smaller the IC50 value. It shows that the higher the compound content in the 
plant part, the greater the anticancer potential in a part of the plant. 
 
CONCLUSION 
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Flower, leaf, stem, and root extracts of C. cinerariifolium have different chemical content and 
differences in T47D cell cytotoxic activity with IC50 values 682.27; 411.43; 170.94; and 
286.58 µg/mL. There is a relationship between the levels of orphenadrine compounds and 
anticancer cytotoxic activity in each part of C. cinerariifolium. The higher the level of 
Orphenadrine compounds in the plant, the higher the potential for anticancer.  
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Table 1. Comparison of the mobile phase system gradient 
Time (second) % Eluent A % Eluent B 
0.00 95.0 5.0 
2.00 75.0 25.0 
3.00 75.0 25.0 
14.00 0.0 100.0 
15.00 0.0 100.0 
19.00 95.0 5.0 
23.00 95.0 5.0 
 
Table 2. Predicted compounds of C.cinerariifolium 
Ethanol 96% Extract of C.cinerariifolium Root 
No. 
Rt 
(minute) 
% Area Measured M/Z Calculated M/Z Formula Compound Name 
1 0,723 0,2283 538,1092 538,1093 C24H22N6O5S2 
3-[(2-{[(4,5-Diphenyl-4H-
1,2,4-triazol-3-yl) 
sulfanyl]acetyl}hydrazino)car
bonyl]-4-
methoxybenzenesulfonamide 
2 0,952 0,2600 171,1114 Unknown Unknown Unknown 
3 1,969 4,4400 202,1318 202,1317 C9H18N2O3 Isoleucine-Alanine dipeptide 
4 3,398 0,7432 216,0905 216,0906 C5H12N8S 
N5-[1-(5-
Tetrazolidinyl)ethyl]-1,2,4-
thiadiazole-3,5-diamine 
5 3,513 0,1509 203,1158 203,1158 C9H17NO4 L-Acetylcarnitine 
6 3,799 0,1501 419,1785 419,178 C23H25N5OS 
2-[(5-Ethyl-5H-
[1,2,4]triazino[5,6-b]indol-3-
yl)sulfanyl]-N-(1-
phenylethyl)butanamide 
 
7 4,164 1,5326 437,2307 437,2306 C20H32N7O2Cl 
1,3-Dimethyl-8-(1-
piperidinyl)-7-[3-(3,4,5,6-
tetrahydro-2-
pyridinylamino)propyl]-3,7-
dihydro-1H-purine-2,6-
dioneHydrochloride 
8 4,645 1,4967 498,1168 498,1171 C26H26O6S2 
1,4-Phenylenebis(methylene) 
bis[2-methoxy- 
4-(methylsulfanyl)benzoate] 
9 4,93 0,8488 516,1270 516,1268 C25H24O12 Cynarine 
10 5,113 0,0569 462,1164 462,1162 C22H22O11 2,2'-[(3,4,5-
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 Trimethoxyphenyl)methylene] 
bis[3-hydroxy-6-
(hydroxymethyl)-4H-pyran-4-
one] 
11 5,296 
0,0534 
 
678,1586 678,1585 C34H30O15 
(3R,5R)-3,4,5-Tris{[(2E)-3-
(3,4-dihydroxyphenyl)-2-
propenoyl]oxy}-1-
hydroxycyclohexanecarboxyli
c acid 
12 5,411 
0,0143 
 
505,2147 505,2148 C27H31N5O3S 
2-{Benzyl[2,2-dimethyl-5-(4-
morpholinyl)1,4-dihydro-2H-
pyrano[4'',3'':4',5']pyrido[3',2':
4,5]thieno[3,2-d]pyrimidin-8-
yl]amino}ethanol 
13 5,628 
0,0879 
 
518,1054 518,1049 C29H18N4O4S 
N'-[(2E)-5-[(3-Oxo-3H-
benzo[f]chromen-2-
yl)carbonyl]-3-phenyl-1,3,4-
thiadiazol-2(3H)-
ylidene]benzohydrazide 
14 5,776 0,0297 358,1893 358,1893 C20H26N2O4 Itopride 
15 5,891 0,0408 194,0943 194,0943 C11H14O3 Butylparaben 
16 6,142 0,0825 213,1524 Unknown H15N13O Unknown 
17 6,257 0,0368 678,1592 Unknown C25H18N20O3S Unknown 
18 6,36 0,0264 592,1793 592,1792 C28H32O14 Acaciin 
19 6,691 
0,1132 
 
460,1000 460,0999 C14H24N2O13S 
(2S,3R,4R,5S)-3-[(2-
Acetamido-2-deoxy-6-O-
sulfo-α-D-
glucopyranosyl)oxy]-4,5-
dihydroxy-2-
piperidinecarboxylic acid 
20 6,76 0,0963 241,1167 241,1678 C13H23NO3 
2-Methyl-2-propanyl 2-
isopropyl-4-oxo-1-
piperidinecarboxylate 
21 6,908 0,0758 296,2143 296,2140 C21H28O Pregna-1,4,20-trien-3-one 
22 7,171 0,1858 411,3136 412,3214 C27H41NO2 Cyclopamine 
23 7,72 0,6027 445,2108 445,2107 C17H31N7O5S Alanylarginylcysteinylproline 
24 7,903 0,6371 589,2517 589,2518 C43H31N3 
3,3',3''-Methanetriyltris(2-
phenyl-1H-indole) 
25 8,52 1,1771 230,0951 230,0950 C7H14N6OS 
3-{2-[(3-Amino-1,2,4-
thiadiazol-5-yl)amino] ethyl}-
1,1-dimethylurea 
26 8,852 
0,7089 
 
439,3814 439,3814 C30H49NO 
(1R,6aR,8S,10aS,12aR)-
7,7,10a,12a-Tetramethyl-1-
[(2R)-6-methyl-5-methylene-
2-heptanyl] 
1,2,3,5,6,6a,7,8,9,10,10a,11,1
2,12a-
tetradecahydronaphtho[1,2-
h]quinolin-8-ol 
27 9,138 2,0262 326,1518 326,1518 C20H22O4 Dentatin 
28 9,367 1,5253 469,2615 469,2617 C31H35NO3 
Cyclohexyl 4-(4-ethylphenyl)-
2-methyl-5-oxo-7-phenyl-
1,4,5,6,7,8-hexahydro-3-
Quinolinecarboxylate 
29 9,469 0,8146 267,1628 Unknown C3H17N13O2 Unknown 
30 9,835 0,8792 770,3297 Unknown C57H42N2O Unknown 
31 10,167 0,8157 293,2366 Unknown C11H31N7S Unknown 
32 10,418 
1,4244 
 
544,2116 544,2117 C26H28N10O2S 
3-Methyl-8-(4-phenyl-1-
piperazinyl)-7-{3-[(1-phenyl-
1H-tetrazol-5-
yl)sulfanyl]propyl}-3,7-
dihydro-1H-purine-2,6-dione 
33 10,933 9,1093 269,1783 269,1780 C18H23NO Orphenadrine 
34 11,413 0,7639 273,2099 Unknown C3H23N13O2 Unknown 
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35 11,596 0,9682 208,1108 Unknown C5H16N6OS 
Unknown 
 
 
36 11,848 0,3086 212,0837 212,0837 C14H12O2 Benzoin 
37 11,996 0,2354 276,2097 Unknown C11H29N6S Unknown 
38 12,179 6,6129 275,2253 275,2249 C18H29NO 
1,3,5-Tris(2-methyl-2-
propanyl)-2-nitrosobenzene 
39 12,396 0,5288 251,2258 Unknown Unknown Unknown 
40 12,545 0,0684 322,1210 322,1212 C13H18N6O2S 
N-(2-Cyano-3-methyl-2-
butanyl)-5,7-
dimethyl[1,2,4]triazolo[1,5-
a]pyrimidine-2-sulfonamide 
41 12,694 0,4986 323,2252 323,2249 C22H29NO 
(E)-1-(4-Butoxyphenyl)-N-(4 
pentylphenyl)methanimine 
42 12,945 7,0016 277,2413 Unknown Unknown Unknown 
43 13,391 0,3227 291,2566 291,2562 C19H33NO 
4-[(Diethylamino)methyl]-
2,6-bis(2-methyl-2-
propanyl)phenol 
44 13,791 4,4868 279,2567 279,2562 C18H33NO Linoleamide 
45 14,157 3,9045 281,2720 281,2719 C18H35NO (9Z)-9-Octadecenimidic Acid 
Ethanol 96% Extract of C.cinerariifolium Stem 
1 0,62 0,1715 174,1121 190,1066 C6H14N4O3 4-Hydroxyarginine 
2 0,837 0,0022 103,1000 103,0977 C5H13NO L-(+)-Valinol 
3 1,42 1,4998 119,9735 119,0735 C8H9N Indoline 
4 1,901 1,6853 202,1321 202,1317 C9H18N2O3 
Isoleucine-
Alanine dipeptide 
5 2,266 0,0741 187,0634 187,0633 C11H9NO2 Indoleacrylic acid 
6 2,449 0,0478 
315,1691 
 
315,1691 
 
C16H29NOS2 
 
N-[2-(1-Cyclohexen-1-
yl)ethyl]-4,4 
bis(ethylsulfanyl)butanami
de 
7 3,364 0,3949 
217,0980 
 
216,0899 
 
C12H12N2O2 
 
3',4'-Dihydro-1'H,2H,5H-
spiro[imidazolidine-4,2'-
naphthalene]-2,5-dione 
8 3,696 
0,3654 
 
441,2626 
 
441,2628 
 
C25H35N3O4 
 
N-{4-[(3-Methoxy-4-{2-
[(2-methyl-2-
propanyl)amino]-2-
oxoethoxybenzyl) 
amino]phenyl}-3-
methylbutanamide 
9 3,947 0,7645 
439,2471 
 
439,2471 
 
C25H33N3O4 
 
N-Isobutyl-N2-{2-[(4-
methoxybenzoyl)amino] 
benzoyl}isoleucinamide 
10 4,096 
0,2378 
 
439,2478 
 
439,2481 
 
C19H39N5O2Cl2 
 
N-(2-{4-[2-(2,5-Dimethyl-
1-pyrrolidinyl)ethyl]-1-
piperazinyl}-2-oxoethyl)-
L-valinamide 
dihydrochloride 
11 4,347 0,2550 
462,0811 
 
462,0812 
 
C22H14N4O8 
 
2,5,7-Trinitro-9-oxo-N-(1-
phenylethyl)-9H-fluorene-
4-carboxamide 
12 4,862 0,9273 
432,1064 
 
432,1063 
 
C14H20N6O8S 
 
L-γ-Glutamyl-S-(1-methyl-
4-nitro-1H-imidazol-5-yl)-
L-cysteinylglycine 
13 5,079 0,2746 
462,1171 
 
462,1171 
 
C23H26O6S2 
 
Bicyclo[2.2.1]hept-5-ene-
2,3-diylbis(methylene) 
bis(4-
methylbenzenesulfonate) 
14 5,479 0,1150 337,2608 Unknown C15H36N5OCl Unknown 
15 5,811 0,0544 225,1368 225,1365 C12H19NO3 Terbutaline 
16 5,959 0,0349 
286,0467 
 
286,0464 
 
C12H2N10 
 
2,2'-[1,2,3]Triazolo[4,5-
f]benzotriazole-
4,8(2H,6H)-
diylidenedimalononitrile 
32 
J. Islamic Pharm. 2019. 4(1): 19-39 
 
J. Islamic Pharm., an open access journal 
ISSN: 2527-6123 
 
17 6,074 0,1311 287,0478 286,0477 C15H10O6 Kaempferol 
18 6,325 
0,0370 
 
592,1804 
 
592,1805 
 
C29H28N4O10 
 
6-[(1,3-Dihydroxy-2-
propanyl)amino]-12-(D-
glucopyranosyl)-2-
hydroxy-12,13-dihydro- 
5H-indolo[2,3-
a]pyrrolo[3,4-c]carbazole-
5,7(6H)-dione 
19 6,84 0,7766 
270,0532 
 
270,0503 
 
C8H18N2O2S3 
 
Methyl {2-[(2-methyl-2-
propanyl)sulfamoyl]ethyl}c
arbamodithioate 
 
 
20 7,057 0,1229 
300,0638 
 
300,0639 
 
C12H9N8Cl 
 
4-Chloro-2-[(6-hydrazino-
1H-pyrazolo[3,4-
d]pyrimidin-4-
yl)amino]benzonitrile 
21 7,24 0,3950 330,0737 330,0740 C17H14O7 Rhamnazin 
22 7,491 0,2355 192,0787 192,0786 C11H12O3 Myristicin 
23 7,972 0,4806 
471,2268 
 
471,2270 
 
C27H29N5O3 
 
Ethyl 4-[7-(4-
ethoxyphenyl)-5-phenyl-
7H-pyrrolo[2,3-
d]pyrimidin-4-yl]-1-
piperazinecarboxylate 
24 8,12 0,0976 
487,2585 
 
487,2583 
 
C28H33N5O3 
 
8-[2-(Adamantan-1-
yl)ethyl]-7-(4-
methoxyphenyl)-1,3-
dimethyl-1H-imidazo[2,1-
f]purine-2,4(3H,8H)-dione 
25 8,521 
0,4004 
 
521,2416 
 
521,2414 
 
C30H35NO7 
 
2-Phenoxyethyl 2,7,7-
trimethyl-5-oxo-4-(2,3,4-
trimethoxyphenyl)-
1,4,5,6,7,8-hexahydro-3-
quinolinecarboxylate 
26 8,635 0,0150 290,1885 290,1882 C18H26O3 Octyl methoxycinnamate 
27 9,184 2,5971 229,1470 229,1467 C15H19NO pronetalol 
28 9,401 0,1554 368,1257 368,1260 C21H20O6 Curcumin 
29 9,835 
1,1838 
 
770,3275 
 
770,3275 
 
C40H46N6O10 
 
2-(1,3-Benzodioxol-5-yl)-
N[(6S,10S,12S,15S,18S)-6- 
benzyl-15-[(1R)-1-
hydroxyethyl]-18-methyl-
4,7,13,16,19-pentaoxo-2-
oxa-5,8,14,17,20-
pentaazatricyclo[21.2.2.08,1
2] 
heptacosa-1(25),23,26-
trien-10-yl] acetamide 
30 10,098 0,4848 315,2780 Unknown Unknown Unknown 
31 10,236 0,1737 303,2209 Unknown Unknown Unknown 
32 10,899 10,1668 269,1784 269,1780 C18H23NO Orphenadrine 
33 11,379 1,2072 285,2093 285,2093 C19H27NO (R)-Pentazocine 
34 11,596 1,0216 208,1098 208,1099 C12H16O3 Asarone 
35 11,813 0,1758 297,2094 297,2093 C20H27NO Butaminophen 
36 11,996 0,2293 365,3268 Unknown Unknown Unknown 
37 12,145 3,9746 
275,2245 
 
275,2249 
 
C18H29NO 
 
1,3,5-Tris(2-methyl-2-
propanyl)-2-nitrosobenzene 
38 12,476 0,5490 341,3300 Unknown Unknown Unknown 
39 12,694 0,3503 323,2254 323,2249 C22H29NO 
p-butoxybenzylidene p-
pentylaniline 
40 12,911 4,1215 277,2408 277,2406 C18H31NO 4-(Dodecyloxy)aniline 
41 13,208 0,0798 
392,2319 
 
392,2320 
 
C22H36N2S2 
 
3-
[(Tetradecylamino)methyl]
-1,3- 
benzothiazole-2(3H)-thione 
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42 13,494 0,1143 267,2566 267,2562 C17H33NO Hexadecyl isocyanate 
43 13,757 1,5396 279,2571 Unknown Unknown Unknown 
44 14,157 3,3119 281,2723 281,2719 C18H35NO Oleamide 
45 14,374 1,458 293,2732 Unknown Unknown Unknown 
46 14,706 0,1309 295,2874 295,2875 C19H37NO 1-Isocyanatooctadecane 
47 15,106 0,1145 333,3027 333,3032 C22H39NO p-Hexadecyloxyaniline 
48 15,289 1,3600 309,3030 309,3032 C20H39NO 1-Hexadecanoylpyrrolidine 
49 15,472 0,0141 
610,4597 
 
610,4597 
 
C39H62O5 
 
[1-(2-{[(3β)-3-Hydroxylup-
20(29)-en-28-yl]oxy}-2-
oxoethyl)cyclopentyl]acetic
 acid 
50 15,586 0,2357 311,3198 Unknown Unknown Unknown 
51 16,204 0,2967 493,5588 493,5587 C34H71N 
N-Hexadecyl-1-
octadecanamine 
52 16,604 0,7435 521,5911 Unknown CH2N2O3S5ClBr3 Unknown 
Ethanol 96% Extract of C.cinerariifolium Leaf 
1 0,586 0,0837 150,0280 150,0277 C3H6N2O5 Urea ethanedioate 
2 0,769 
0,0398 
 
292,0567 292,0565 C11H12N6S2 
9-Methyl-5-
(methylsulfanyl)-8,9,10,11-
tetrahydropyrido[4',3':4,5]t
hieno[3,2-e]tetrazolo[1,5-
c]pyrimidine 
3 1,42 1,0781 119,0735 119,0735 C8H9N Indoline 
4 1,935 0,1100 202,1318 202,1317 C9H18N2O3 Isoleucyl-Alanine 
5 2,266 0,7538 187,0634 187,0633 C11H9NO2 Indoleacrylic acid 
6 2,518 0,0526 185,1163 185,1164 
C8H15N3O2 
 
1-Acetyl-3-
piperidinecarbohydrazide 
7 3,364 0,2818 216,0902 216,0899 
C12H12N2O2 
 
3',4'-Dihydro-1'H,2H,5H-
spiro[imidazolidine-4,2'-
naphthalene]-2,5-dione 
8 3,764 0,3684 243,1474 243,1471 C12H21NO4 Tiglylcarnitine 
9 3,947 
0,3261 
 
439,2475 439,2471 
C25H33N3O4 
 
N-Isobutyl-N2-{2-[(4-
methoxybenzoyl)amino]be
nzoyl} 
isoleucinamide 
10 4,347 
0,1707 
 
462,0800 462,0798 
C17H23N4O5S2Cl 
 
4-Chloro-2-({4-[(2,6-
dimethyl-4-
morpholinyl)sulfonyl]-1-
piperazinyl}sulfonyl)benzo
nitrile 
11 4,645 0,1249 578,1638 578,1636 C27H30O14 Kaempferitrin 
12 4,862 0,5915 446,0862 446,0862 
C22H14N4O7 
 
N-[(1,3-Dioxo-1,3-dihydro-
2H-isoindol-2-yl)methyl]-
3,5-dinitro-N-
phenylbenzamide 
13 5,262 0,0129 349,2245 Unknown C15H32N5O2Cl Unknown 
14 5,662 
0,0720 
 
527,1920 527,1922 
C25H34NO9Cl 
 
1-(Nitrooxy)-2-
propanyl(5Z)-7-
{(1R,2R,3R,5S)-2-
[(1E,3R)-4-(3-
chlorophenoxy)-3-hydroxy-
1-buten-1-yl]-3,5-
dihydroxycyclopentyl}-5-
heptenoate 
15 5,776 
0,1556 
 
459,2259 459,2257 
C25H33NO7 
 
2-Methoxyethyl 2,7,7-
trimethyl-5-oxo-4-(3,4,5-
trimethoxyphenyl)-
1,4,5,6,7,8-hexahydro-3-
quinolinecarboxylate 
16 6,074 0,2245 286,0479 286,0477 C15H10O6 Kaempferol 
17 6,257 0,1001 316,0585 316,0583 C16H12O7 Isorhamnetin 
18 6,84 1,7179 270,0533 270,0528 C15H10O5 Genistein 
19 7,274 1,8113 330,0737 330,0740 
C13H19N4S2Cl 
 
N-[(5-Chloro-1,2,3-
thiadiazol-4-yl)methyl]-1-
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(2-isopropyl-4-methyl-1,3-
thiazol-5-yl)-N-
methylethanamine 
20 7,572 
0,0101 
 
488,2162 488,2159 
C25H32N2O8 
 
(2-Methyl-1,4-
piperazinediyl)bis[(3,4,5-
trimethoxyphenyl)methano
ne] 
21 7,674 0,0150 309,2302 309,2304 
C18H31NO3 
 
N,N-Diisobutyl-4,7,7-
trimethyl-3-oxo-2-
oxabicyclo[2.2.1]heptane-
1-carboxamide 
22 7,972 
0,2336 
 
471,2255 471,2257 
C26H33NO7 
 
2-Methoxyethyl 4-(4-
acetoxy-3-ethoxyphenyl)-
2,7,7-trimethyl-5-oxo-
1,4,5,6,7,8-hexahydro-3-
quinolinecarboxylate 
23 8,223 
0,0365 
 
344,0906 344,0905 
C19H20O2S2 
 
2-(7,8-Dimethyl-1,5-
dihydro-2,4-
benzodithiepin-3-yl)phenyl 
acetate 
24 8,406 0,0689 234,1627 Unknown C8H22N6S Unknown 
25 8,52 
0,0225 
 
521,2415 521,2414 
C30H35NO7 
 
2-Phenoxyethyl 2,7,7-
trimethyl-5-oxo-4-(2,3,4-
trimethoxyphenyl)-
1,4,5,6,7,8-hexahydro-3-
quinolinecarboxylate 
26 9,138 0,4170 229,1472 229,1467 C15H19NO Pronetalol 
27 9,652 0,0098 403,1164 403,1168 C22H17N3O5 Azoxystrobin 
28 10,235 0,1533 218,1672 218,1671 C15H22O (+)-Nootkatone 
29 10,716 0,5352 267,1622 267,1623 C18H21NO Azacyclonol 
30 10,899 3,2354 269,1780 269,1780 C18H23NO Orphenadrine 
31 11,379 0,5113 387,0986 387,0986 C19H18N3O4Cl Pyraclostrobin 
32 11,596 0,1104 519,3324 519,3322 
C29H41N7O2 
 
3-[(4-Cyclohexyl-1-
piperazinyl)(1-cyclohexyl-
1H-tetrazol-5-yl)methyl]-6-
ethoxy-2(1H)-quinolinone 
33 12,145 1,0840 275,2257 Unknown Unknown Unknown 
Ethanol 96% Extract of C.cinerariifolium Flower 
1 0,62 0,2307 174,1122 174,1117 C6H14N4O2 L-Arginine 
2 1,42 1,5649 119,0736 119,0735 C8H9N Indoline 
3 1,901 1,9443 202,1319 202,1317 C9H18N2O3 
Isoleucine-
Alanine dipeptide 
4 2,266 2,1291 187,0639 187,0633 C11H9NO2 Indoleacrylic acid 
5 3,364 
0,5735 
 
441,2623 441,2628 
C25H35N3O4 
 
N-{4-[(3-Methoxy-4-{2-
[(2-methyl-2-
propanyl)amino]-2-
oxoethoxy}benzyl)amino]p
henyl}-3-
methylbutanamide 
6 3,947 1,5082 439,2469 439,2471 
C25H33N3O4 
 
N-Isobutyl-N2-{2-[(4-
methoxybenzoyl)amino]be
nzoyl} 
isoleucinamide 
7 4,862 
3,7310 
 
432,1057 432,1056 
C21H20O10 
 
5-Hydroxy-3-(4-
hydroxyphenyl)-4-oxo-4H-
chromen-7-yl 
hexopyranoside 
8 5,479 1,9686 640,3257 640,3254 
C29H48N6O8S 
 
L-Lysyl-L-leucyl-L-
methionyl-L-seryl-L-
tyrosine 
9 5,959 2,1848 286,0490 286,0486 
C16H14OS2 
 
(2Z,6E)-2,6-Bis(2-
thienylmethylene)cyclohex
anone 
10 6,108 1,962 286,0480 286,0480 C8H18N2O3S3 2-
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 {[3(Methylsulfinyl)propyl] 
sulfamoyl}butanethioamide 
11 6,325 0,1416 592,1790 592,1792 C28H32O14 Acaciin 
12 6,394 
0,0817 
 
474,1152 474,1150 
C28H18N4O2S 
 
3-(4-Methylbenzoyl)-2-(4-
phenyl-2-thioxo-1,2,3,4-
tetrahydro-5-pyrimidinyl)-
1- 
benzofuran-5,6-
dicarbonitrile 
13 6,84 3,1285 270,0531 270,0530 
C8H18N2O2S3 
 
Methyl {2-[(2-methyl-2-
propanyl)sulfamoyl]ethyl}
Carbamodithioate 
14 7,24 1,5010 360,0846 360,0845 C18H16O8 (R)-(+)-rosmarinic acid 
15 7,572 0,1700 488,2156 488,2159 
C25H32N2O8 
 
(2-Methyl-1,4-
piperazinediyl)bis[(3,4,5 
trimethoxyphenyl)methano
ne] 
16 7,972 1,0043 471,2262 471,2262 
C22H30N9OCl 
 
N-{2-[(7-Chloro-4-
quinolinyl)amino]ethyl}-
N'-[2-
(dimethylamino)ethyl]-6-
(4-morpholinyl)-1,3,5-
triazine-2,4-diamine 
17 8,223 0,6838 344,0897 344,0896 C18H16O7 (±)-Usnic acid 
18 8,406 0,3363 271,1210 271,1208 C16H17NO3 O-Benzyl-L-tyrosine 
19 8,669 0,1494 284,0687 284,0687 
C9H20N2O2S3 
 
(3-Methyl-1,1-
dioxidotetrahydro-3-
thiophenyl)carbamodithioic 
acid–N,N-
dimethylmethanamine 
20 9,401 10,8649 285,1367 285,1265 C17H19NO3 D-(-)-Morphine 
21 9,584 
6,7201 
 
285,1375 285,1375 
C11H25N3OCl2 
 
2-[4-(4-Piperidinyl)-1-
piperazinyl] 
ethanol Dihydrochloride 
22 9,835 0,3062 277,1473 Unknown C4H15N13O2 Unknown 
23 9,984 
0,0280 
 
291,2200 291,2198 
C18H29NO2 
 
1-(2-Cyclopentylphenoxy)-
3-[(2-methyl-2-
propanyl)amino]-2-
propanol 
24 10,281 3,4908 311,1524 311,1521 C19H21NO3 Nalorphine 
25 10,75 2,8304 267,1624 267,1263 C18H21NO Azacyclonol 
26 10,899 8,6205 269,1785 269,1780 C18H23NO Orphenadrine 
27 11,264 1,8554 339,1833 339,1834 C21H25NO3 Pipethanate 
28 11,413 2,5239 285,2094 285,2093 C19H27NO (R)-Pentazocine 
29 11,596 
0,7026 
 
519,3323 519,3322 
C29H41N7O2 
 
3-[(4-Cyclohexyl-1-
piperazinyl)(1-cyclohexyl-
1H-tetrazol-5-yl)methyl]-6-
ethoxy-2(1H)-quinolinone 
30 11,962 3,1903 343,2147 343,2147 C21H29NO3 Smenospongine 
31 12,179 4,9042 275,2253 275,2259 
C18H29NO 
 
1,3,5-Tris(2-methyl-2-
propanyl)-2-nitrosobenzene 
32 12,396 0,5785 251,2252 251,2249 
C16H29NO 
 
(6Z,8S,8aS)-8-Methyl-6-
[(2R)-2-
methylhexylidene]octahydr
o-8-indolizinol 
 
33 12,694 1,1111 323,2249 323,2249 
C22H29NO 
 
(E)-1-(4-Butoxyphenyl)-N-
(4-
pentylphenyl)methanimine 
34 12,911 4,6764 277,2411 277,2406 C18H31NO 4-(Dodecyloxy)aniline 
35 13,345 0,0842 602,5275 602,5274 
C39H70O4 
 
(2S)-1-(Hexadecyloxy)-3-
hydroxy-2-propanyl 
5,8,11,14-icosatetraenoate 
36 13,757 1,3846 279,2566 279,2562 C18H33NO Linoleamide 
36 
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Table 3. IC50 value of T47D cell line after treatment with C. cinerariifolium 
Sample IC50 T47D cell line ± SD (%)* 
Flower 782,33 µg/mL ± 13,98 
Leave 362,58 µg/mL ± 19,07 
Stem 168,46 µg/mL ± 5,83 
Root  293,81 µg/mL ± 12,40 
Doxorubicin 208,82 nM      ± 22,95 
Description: 
*SD : standard deviation in treatment with 3x repetition 
 
Table 4. Correlation test result of orphenadrine and cytotoxic activity  
 Orpenadrine T47D cell 
Orphenadrine 
Pearson correlation 
Sig. (2-tailed) 
1 
-.859** 
.003* 
T47D cell 
Pearson correlation 
Sig. (2-tailed) 
-.859** 
.003* 
1 
Vero cell 
Pearson correlation 
Sig. (2-tailed) 
-.872** 
.002* 
 
Description: 
* : p < 0.05 
**: Correlations negative 
 
Figure 1. Resuts of identification C. cinerariifolium with TLC Visualyzer. Silica gel GF254 
as Stationary phase, n-hexane: ethyl acetate 4:1 as mobile phase. Root extract 
(ER); stems extract (ES); flower extract (EF); and leave extract (EL). (A) TLC 
plates with UV 366 light not derivated, and (B) with derivated. 
 
 
          ER    ES     EF     EL                          ER     ES     EF    EL 
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Figure 2. The results of chromatogram C. cinerariifolium extract. A) Chromatogram of roots 
extract; B) Chromatogram of stems extract; C) Chromatogram of leaves extract; 
D) Chromatogram of flowers extract.  
 
 
Figure 3. Spectra m/z and structure of Orphenadrine  
 
Farmasi UIN Malang
m/z
50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250 1300 1350 1400 1450
%
0
100
Nia Ayu Sample 01 Akar Met 299 (10.933) Cm (299) 1: TOF MS ES+ 
1.94e7x10 270.1861
224.2017
128.0627
115.0549
91.0555
171.1175
268.1703
225.2041
272.1991
294.2437
539.3628
304.2992
322.2164
518.3243
457.3670327.1585 425.1961
540.3657
562.3491
563.4199
602.5213
!
650.3519 701.4187 !
831.5331 892.4888
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Figure 4. Spectra m/z and structure of D-(-)-Morphine 
 
 
Figure 5. Spectra m/z and structure of N-[(5-Chloro-1,2,3-thiadiazol-4-yl)methyl]-1-(2-
isopropyl-4-methyl-1,3-thiazol-5-yl)-N-methylethanamine 
 
 
Figure 6. Spectra m/z and structure of Genistein 
 
Farmasi UIN Malang
m/z
50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250 1300 1350 1400 1450
%
0
100
Nia Ayu Sample 04 Bunga Met 257 (9.401) Cm (257) 1: TOF MS ES+ 
3.68e7x16 286.1446
201.0554
115.0549
105.0705
152.0624
274.2173
268.1703
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288.1512
369.1329
298.1446
314.2093
!;367.1538
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499.1963
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!
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!
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Farmasi UIN Malang
m/z
50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250 1300 1350 1400 1450
%
0
100
Nia Ayu Sample 03 Daun Met 199 (7.274) Cm (199) 1: TOF MS ES+ 
1.14e7x4 331.0815
316.0578
201.1640
159.1168
115.054391.0550
288.1958219.1745
233.1534
332.0848
361.0905
714.0639
416.2426
685.1096
!
472.2163
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!
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!
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0
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1.08e7x4 271.0614
233.1548217.1597
175.1125115.054537.8808
272.0643
273.0699
301.0716
466.2614
352.2119 439.2597
!
594.0289
506.2369528.2023 595.0300
!
650.3261
!
697.2997 !
834.3584
!
752.4264
!
934.4303
!
885.3810
!
960.5020
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Figure 7. The results of statistical analysis using Principal Component Analysis (PCA). A) 
Loading plot shows marker compound; B) Show plot closeness compound score 
on the part of C. cinerariifolium; C) Score plot shows compound compounds 
which have similarity and difference physical and chemical characteristic. 
 
 
Figure 8. Viability of T47D cells due to the administration of the flowers, stem leaves and 
roots of extract C. cinerarifolium (A). Viability of T47D cells due to the 
administration of doxorubicin as a comparison. 
 
